Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1α metabotropic glutamate receptor

被引：47
|
作者：
Hermans, E [1 ]
Nahorski, SR [1 ]
Challiss, RAJ [1 ]
机构：
[1] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
来源：
NEUROPHARMACOLOGY | 1998年 / 37卷 / 12期
基金：
英国惠康基金;
关键词：
glutamate; mGlu1 alpha receptor; phosphoinositide hydrolysis; non-competitive antagonist; CPCCOEt;
D O I：
10.1016/S0028-3908(98)00132-4
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
In transfected CHO cells expressing the human metabotropic glutamate receptor mGlu1 alpha, 7- hydroxyimino)cyclopropan[b]chromen-1a-carboxylic acid ethylester (CPCCOEt) was found to antagonize L-quisqualate-induced phosphoinositide hydrolysis in a non-competitive and reversible manner (apparent pK(i) value, 4.76 +/- 0.18: It = 3. This suggests that CPCCOEt antagonizes type Ir metabotropic glutamate receptor activation by interacting with a site distinct from the agonist binding site. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1645 / 1647
页数：3
相关论文
共 50 条
  • [41] The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra
    Wedzony, K
    Czyrak, A
    Mackowiak, M
    Fijal, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (05) : 517 - 527
  • [42] Discovery and biological profile of a new class of metabotropic receptor 1 allosteric antagonist
    Itoh, S
    Satoh, A
    Nagatomi, Y
    Hirata, Y
    Suzuki, G
    Kimura, T
    Satow, A
    Hata, M
    Kawamoto, H
    Ohta, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2533 - U2533
  • [43] Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models
    Kohara, Atsuyuki
    Takahashi, Masayasu
    Yatsugi, Shin-ichi
    Tamura, Seiji
    Shitaka, Yoshitsugu
    Hayashibe, Satoshi
    Kawabata, Shigeki
    Okada, Masamichi
    BRAIN RESEARCH, 2008, 1191 : 168 - 179
  • [44] Type-1 metabotropic glutamate receptor regulates adenosine A1 receptor signaling
    Sakairi, Hakushun
    Kamikubo, Yuji
    Sakurai, Takashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S153 - S153
  • [45] The analgesic effect of agmatine in formalin-induced pain is enhanced by a non-competitive NMDA receptor antagonist
    Sizuoka, Yoshikatsu
    Ariyoshi, Toru
    Nakanishi, Osamu
    Fukuhara, Kayoko
    Yamamoto, Satoru
    Yamamoto, Misa
    Ishikawa, Toshizo
    PAIN RESEARCH, 2010, 25 (01) : 55 - 63
  • [46] Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice
    Suzuki, T
    Kato, H
    Aoki, T
    Tsuda, M
    Narita, M
    Misawa, M
    LIFE SCIENCES, 2000, 67 (04) : 383 - 389
  • [47] Effects of Memantine, a Non-Competitive N-Methyl-D-Aspartate Receptor Antagonist, on Genomic Stability
    Flores, Edina Madeira
    Cappelari, Shandale Emanuele
    Pereira, Patricia
    Picada, Jaqueline Nascimento
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 (05) : 413 - 417
  • [48] Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord
    Ebert, B
    Mikkelsen, S
    Thorkildsen, C
    Borgbjerg, FM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 333 (01) : 99 - 104
  • [49] Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells
    Gelb, Tara
    Pshenichkin, Sergey
    Hathaway, Hannah A.
    Grajkowska, Ewa
    Dalley, Carrie Bowman
    Wolfe, Barry B.
    Wroblewski, Jarda T.
    BIOCHEMICAL PHARMACOLOGY, 2015, 98 (01) : 182 - 189
  • [50] MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist
    Anna Janus
    Klaudia Lustyk
    Karolina Pytka
    Psychopharmacology, 2023, 240 : 2435 - 2457
12345